Why is Vanda Pharmaceuticals stock rallying today?

More in Finance

• This credit card is the ‘best weapon’ to fight debt while interest rates keep climbing

  Americans carrying credit-card balances face growing financial pressure as borrowing costs are projected to climb higher through the end of the year. Recent policy shifts have compounded the burden, following a rate hike in September and an additional increase scheduled for December. Selecting the right credit card has emerged as a crucial strategy for consumers trying to shield themselves from accelerating debt.

  1 min read
• Poland stocks higher at close of trade; WIG30 up 0.82%

  Equities in Poland concluded trading with solid positive momentum across the exchange floor. The upward movement reflected sustained buying interest as investors pushed key benchmark assets into green territory by the closing bell. This solid performance concludes the latest market session with overall gains for regional equities.

  1 min read
• Lilly’s obesity drug strength fuels record rally, Wall Street optimism

  Investor enthusiasm continues to mount as clinical and commercial momentum around Eli Lilly's weight-loss treatments propels unprecedented market gains. Financial analysts are increasingly bullish on the pharmaceutical giant's growth prospects, viewing its metabolic pipeline as a primary growth engine. This surge reflects widespread confidence across financial markets regarding the long-term revenue potential of next-generation obesity therapies.

  1 min read